Guardant Health partners with Quest for blood-based cancer screening
Go back to Guardant Health partners with Quest for blood-based cancer screening| Quest Diagnostics (NYSE: DGX) | Delayed: 237.14 -2.26 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $239.40 | 52 Week High | $86.85 | |||
| Open | $235.38 | 52 Week Low | $59.66 | |||
| Day High | $238.92 | P/E | 44.66 | |||
| Day Low | $235.38 | EPS | $5.31 | |||
| Volume | 798,704 | |||||
| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 161.41 +0.37 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.04 | 52 Week High | $5.84 | |||
| Open | $160.00 | 52 Week Low | $5.49 | |||
| Day High | $164.84 | P/E | N/A | |||
| Day Low | $154.00 | EPS | $0.00 | |||
| Volume | 2,402,425 | |||||
